Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretary baculovirus system

Journal of General Virology

Volumn 78, Issue 11, 1997, Pages 2723-2733

  Bielefeldt Ohmann, Helle ^a   Beasley, David W C ^a   Fitzpatrick, David R ^b   Aaskov, John G ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; HYBRID PROTEIN; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; MELITTIN; MONOCLONAL ANTIBODY; SIGNAL PEPTIDE; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; CULTURE MEDIUM; DENGUE VIRUS; FEMALE; FLAVIVIRUS; IMMUNOGENICITY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN SECRETION; SUPERNATANT; T LYMPHOCYTE; VIRION; VIRUS RECOMBINANT;

ANIMALIA; DENGUE VIRUS; DENGUE VIRUS TYPE 2; DENGUE VIRUS TYPE 3; FLAVIVIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0030671054     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-11-2723     Document Type: Article

References (49)

1. Aaskov, J. G., Williams, L., Fletcher, J. & Hay, R. (1988). Failure of a dengue 1 subunit vaccine to protect mice against a lethal dengue virus infection. American Journal of Tropical Medicine and Hygiene 39, 511-518.
2. Aaskov, J. G., Geysen, H. M. & Mason, T. J. (1989). Serobgically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409). Archives of Virology 105, 209-221.
3. Barrios, C., Brawand, P., Berney, M., Brandt, C., Lambert, P. H. & Siegrist, C. A. (1996). Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persist after adult boosting. European Journal of Immunology 26, 1489-1496.
4. Baxter, G. D. & Lavin, M. F. (1992). Specific protein dephosphorylation in apoptosis induced by ionizing radiation and heat shock in human lymphoid tumor lines. Journal of Immunology 148, 1949-1954.
5. Bhamarapravati, N. & Yoksan, S. (1989). Study of bivalent dengue vaccine in volunteers. Lancet i, 1077.
6. Bielefeldt-Ohmann, H., Marzo, A., Fitzpatrick, D. R., Jarnicki, A., Davis, M., Manning, L. S. & Robinson, B. W. S. (1994). Immunobiology of murine malignant mesothelioma (MM): characterisation of tumour infiltrating leukocytes and cytokine production in a murine model of MM. Cancer Immunology Immunotherapy 39, 347-359.
7. Brandt, W. E., McCown, J. M., Gentry, M. K. & Russell, P. K. (1982). Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants. Infection and Immunity 36, 1036-1041.
8. Bray, M. & Lai, C. J. (1991). Construction of chimeric dengue virus by substitution of structural protein genes. Proceedings of the National Academy of Sciences, USA 88, 10342-10346.
9. Bretscher, P. A., Wei, G. J., Menon, J. N. & Bielefeldt-Ohmann, H. (1992). Establishment of stable, cell-mediated immunity that makes susceptible mice resistant to Leishmania major. Science 257, 539-542.
10. Cecilia, D. & Gould, E. A. (1991). Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis vims neutralization-resistant mutants. Virology 181, 70-77.
11. Chen, W., Kawano, H., Men, R., Clark, D. & Lai, C. J. (1995). Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice. Journal of Virology 69, 5186-5190.
12. Chu, M. C., O'Rourke, E. J. & Trent, D. W. (1989). Genetic relatedness among structural protein genes of dengue 1 virus strains. Journal of General Virology 70, 1701-1712.
13. Coffman, R. L., Lebman, D. A. & Rothman, R. (1993). Mechanisms and regulation of immunoglobulin isotype switching. Advances in Immunology 54, 229-270.
14. Constant, S., Pfeiffer, C., Woodard, A., Pasqualini, T. & Bottomley, K. (1995). Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells. Journal of Experimental Medicine 182, 1591-1596.
15. Delenda, C., Staropoli, I., Frenkiel, M. P., Cabanie, L. & Deubel, V. (1994). Analysis of C-terminally truncated dengue 2 and dengue 3 virus envelope glycoproteins: processing in insect cells and immunogenic properties in mice. Journal of General Virology 75, 1569-1578.
16. Deubel, V., Bordier, M., Megret, F., Gentry, M. K., Schlesinger, J. J. & Girard, M. (1991). Processing, secretion, and immunoreactivity of carboxy terminally truncated dengue-2 virus envelope proteins expressed in insect cells by recombinant baculoviruses. Virology 180, 442-447.
17. Deubel, V., Nogueira, R. M., Drouet, M. T., Zeller, H., Reynes, J. M. & Ha, D. Q. (1993). Direct sequencing of genomic cDNA fragments amplified by PCR for molecular epidemiology of dengue-2 viruses. Archives of Virology 129, 197-210.
18. Fitzpatrick, D. R. & Kelso, A. (1995). Dissociated expression of granulocyte-macrophage CSF and IL-3 in short-term T cell clones from normal mice. Journal of Immunology 155, 5140-5150.
19. Gentry, M. K., Henchal, E. A., McCown, J. M., Brandt, W. E. & Dalrymple, J. M. (1982). Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 31, 548-553.
20. Halstead, S. B., Shotwell, H. & Casals, J. (1973). Studies of the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. Journal of Infectious Diseases 128, 15-22.
21. Harris, P. & Ralph, P. (1985). Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. Journal of Leukocyte Biology 37, 407-422.
22. Hocart, M. J., MacKenzie, J. S. & Stewart, G. A. (1989). The immunoglobulin G subclass responses of mice to influenza A virus: the effect of mouse strain, and the neutralizing abilities of individual protein A-purified subclass antibodies. Journal of General Virology 70, 2439-2448.
23. Hosken, N. A., Shibuya, K., Heath, A. W., Murphey, K. M. & O'Garra, A. (1995). The effect of antigen dose on CD4 + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. Journal of Experimental Medicine 182, 1579-1584.
24. Innis, B. L., Thirawuth, V. & Hemachudha, C. (1989). Identification of continuous epitopes of the envelope glycoprotein of dengue type 2 virus. American Journal of Tropical Medicine and Hygiene 40, 676-687.
25. Jiang, W. R., Lowe, A., Higgs, S., Reid, H. & Gould, E. A. (1993). Single amino acid codon changes detected in Louping III virus antibody-resistant mutants with reduced neurovirulence. Journal of General Virology 74, 931-935.
26. Jianmin, Z., Linn, M. L., Bilich, R., Gentry, M. K. & Aaskov, J. G. (1995). Analysis of functional epitopes on the dengue 2 E protein using monoclonal IgM antibodies. Archives of Virology 140, 899-913.
27. Johnson, A. J., Guirakhoo, F. & Roehrig, J. T. (1994). The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology 203, 241-249.
28. Kulkarni, A. B., Mullbacher, A., Parrish, C. R., Westaway, E. G., Coia, G. & Blanden, R. V. (1992). Analysis of murine major histocompatibility complex class II-restricted T-cell responses to the flavivirus Kunjin by using vaccinia virus expression. Journal of Virology 66, 3583-3592.
29. Lanciotti, R. S., Lewis, J. G., Gubler, D. J. & Trent, D. W. (1994). Molecular evolution and epidemiology of dengue-3 viruses. Journal of General Virology 75, 65-75.
30. Levine, B., Hardwick, J. M., Trapp, B. D., Crawford, T. O., Bollinger, R. C. & Griffin, D. E. (1991). Antibody-mediated clearance of alphavirus infection from neurons. Science 254, 856-860.
31. Lin, B., Parrish, C. R., Murray, J. M. & Wright, P. J. (1994). Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology 202, 885-890.
32. Lobigs, M., Dalgarno, L., Schlesinger, J. J. & Weir, R. C. (1987). Location of a neutralization determinant in the E protein of yellow fever virus. Virology 161, 474-478.
33. Maraskovsky, E., Troutt, A. B. & Kelso, A. (1992). Co-engagement of CD3 with LFA-1 or ICAM-1 adhesion molecules enhances the frequency of activation of single murine CD4 + and CD8 + T cells and induces synthesis of IL-3 and IFN-γ but not IL-4 or IL-6. International Immunology 4, 475-485.
34. Megret, F., Hugnoy, J. P., Falconer, A., Gentry, M. K., Morens, D. M., Murray, J. M., Schlesinger, J. J., Wright, P. J., Young, P., Van Regenmortel, H. V. & Deubel, V. (1992). Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 187, 480-491.
35. Monath, T. P. (1994). Yellow fever and dengue - the interactions of virus, vector and host in the re-emergence of epidemic disease. Seminars in Virology 5, 133-145.
36. Morens, D. M. (1994). Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clinical Infectious Diseases 19, 500-512.
37. Mroczkowski, B. S., Huvar, A., Lernhardt, W., Misono, K., Nielson, K. & Scott, B. (1994). Secretion of thermostable DNA polymerase using a novel baculovirus vector. Journal of Biological Chemistry 269, 13522-13528.
38. O'Reilly, D. R., Miller, L. K. & Luckow, V. A. (1994). Baculovirus Expression Vectors: A Laboratory Manual. New York: Oxford University Press.
39. Putnak, R., Feighny, R., Burrous, J., Cochran, M., Hackett, C., Smith, G. & Hoke, C. (1991). Dengue-1 virus envelope glycoprotein gene expressed in recombinant baculovirus elicits virus-neutralizing antibody in mice and protects them from virus challenge. American Journal of Tropical Medicine and Hygiene 45, 159-167.
40. Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. (1995). The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature 375, 291-298.
41. Richardson, C. D. (1995). Baculovirus expression protocols. Methods in Molecular Biology, vol. 39.
42. Roehrig, J. T., Ris, P. A., Brubaker, J. R., Hunt, A. R., Beaty, B. J., Trent, D. W. & Mathews, J. H. (1994). T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology 198, 31-38.
43. Sarzotti, M., Robbins, D. S. & Hoffman, P. M. (1996). Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271, 1726-1728.
44. Schlesinger, R. W. (1977). Dengue Viruses. New York.-Springer-Verlag.
45. Seto, N. O., Ou, D. & Gillam, S. (1995). Expression and characterization of secreted forms of rubella virus E2 glycoprotein in insect cells. Virology 206, 736-741.
46. Smucny, J. J., Kelly, E. P., Macarthy, P. O. & King, A. D. (1995). Murine immunoglobulin G subclass responses following immunization with live dengue virus or a recombinant dengue envelope protein. American Journal of Tropical Medicine and Hygiene 53, 432-437.
47. Staropoli, I., Clement, J. M., Frenkiel, M. P., Hofnung, M. & Deubel, V. (1996). Dengue virus envelope glycoprotein can be secreted from insect cells as fusion with the maltose-binding protein. Journal of Virological Methods 56, 179-189.
48. Staton, J. M., Dench, J. E., Currie, B., Fitzpatrick, D. R., Himbeck, R. P., Allen, R., Bruce, J., Robinson, B. & Bielefeldt-Ohmann, H. (1995). Tissue-expression and immune recognition of stress proteins in sarcoidosis and other chronic lung diseases. Immunology and Cell Biology 73, 23-32.
49. Trirawatanapong, T., Chandran, B., Putnak, R. & Padmanabhan, R. (1992). Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody. Gene 116, 139-150.